nodes	percent_of_prediction	percent_of_DWPC	metapath
Hyoscyamine—CHRM3—ureter—colon cancer	0.0774	0.514	CbGeAlD
Hyoscyamine—CHRM3—muscle of abdomen—colon cancer	0.0557	0.37	CbGeAlD
Hyoscyamine—CHRM3—smooth muscle tissue—colon cancer	0.00639	0.0424	CbGeAlD
Hyoscyamine—CHRM3—renal system—colon cancer	0.00615	0.0408	CbGeAlD
Hyoscyamine—CHRM3—digestive system—colon cancer	0.00505	0.0335	CbGeAlD
Hyoscyamine—Ventricular fibrillation—Capecitabine—colon cancer	0.00425	0.00501	CcSEcCtD
Hyoscyamine—Rash maculo-papular—Fluorouracil—colon cancer	0.00424	0.00499	CcSEcCtD
Hyoscyamine—Ageusia—Capecitabine—colon cancer	0.00402	0.00473	CcSEcCtD
Hyoscyamine—Petechiae—Capecitabine—colon cancer	0.00396	0.00466	CcSEcCtD
Hyoscyamine—Extrasystoles—Capecitabine—colon cancer	0.00387	0.00456	CcSEcCtD
Hyoscyamine—Swelling—Fluorouracil—colon cancer	0.00384	0.00452	CcSEcCtD
Hyoscyamine—Disorientation—Fluorouracil—colon cancer	0.00378	0.00445	CcSEcCtD
Hyoscyamine—Hyponatraemia—Vincristine—colon cancer	0.00364	0.00429	CcSEcCtD
Hyoscyamine—Gastrooesophageal reflux disease—Capecitabine—colon cancer	0.00361	0.00425	CcSEcCtD
Hyoscyamine—Ventricular extrasystoles—Capecitabine—colon cancer	0.00361	0.00425	CcSEcCtD
Hyoscyamine—Amnesia—Fluorouracil—colon cancer	0.0036	0.00424	CcSEcCtD
Hyoscyamine—Hyponatraemia—Irinotecan—colon cancer	0.00355	0.00418	CcSEcCtD
Hyoscyamine—Osteoarthritis—Irinotecan—colon cancer	0.00353	0.00416	CcSEcCtD
Hyoscyamine—Paralysis—Methotrexate—colon cancer	0.00349	0.00411	CcSEcCtD
Hyoscyamine—Lethargy—Fluorouracil—colon cancer	0.00345	0.00407	CcSEcCtD
Hyoscyamine—Cardiac arrest—Vincristine—colon cancer	0.00345	0.00406	CcSEcCtD
Hyoscyamine—Urinary retention—Vincristine—colon cancer	0.00345	0.00406	CcSEcCtD
Hyoscyamine—Dysarthria—Capecitabine—colon cancer	0.00344	0.00405	CcSEcCtD
Hyoscyamine—Cyanosis—Methotrexate—colon cancer	0.00343	0.00403	CcSEcCtD
Hyoscyamine—Ataxia—Vincristine—colon cancer	0.00341	0.00402	CcSEcCtD
Hyoscyamine—Osteoarthritis—Fluorouracil—colon cancer	0.00338	0.00398	CcSEcCtD
Hyoscyamine—Dehydration—Vincristine—colon cancer	0.00337	0.00397	CcSEcCtD
Hyoscyamine—Cardiac arrest—Irinotecan—colon cancer	0.00336	0.00396	CcSEcCtD
Hyoscyamine—Dehydration—Irinotecan—colon cancer	0.00329	0.00387	CcSEcCtD
Hyoscyamine—Blood pressure increased—Capecitabine—colon cancer	0.00326	0.00384	CcSEcCtD
Hyoscyamine—Stupor—Methotrexate—colon cancer	0.00325	0.00382	CcSEcCtD
Hyoscyamine—Injection site reaction—Capecitabine—colon cancer	0.00324	0.00381	CcSEcCtD
Hyoscyamine—Irritability—Fluorouracil—colon cancer	0.00323	0.0038	CcSEcCtD
Hyoscyamine—Cardiac arrest—Fluorouracil—colon cancer	0.00322	0.00379	CcSEcCtD
Hyoscyamine—Hypokalaemia—Irinotecan—colon cancer	0.00321	0.00379	CcSEcCtD
Hyoscyamine—Ataxia—Fluorouracil—colon cancer	0.00318	0.00375	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Capecitabine—colon cancer	0.00314	0.0037	CcSEcCtD
Hyoscyamine—Skin exfoliation—Capecitabine—colon cancer	0.00311	0.00366	CcSEcCtD
Hyoscyamine—Dry skin—Fluorouracil—colon cancer	0.0031	0.00365	CcSEcCtD
Hyoscyamine—Abdominal distension—Irinotecan—colon cancer	0.00307	0.00362	CcSEcCtD
Hyoscyamine—Dry eye—Capecitabine—colon cancer	0.00301	0.00354	CcSEcCtD
Hyoscyamine—Angina pectoris—Irinotecan—colon cancer	0.00297	0.0035	CcSEcCtD
Hyoscyamine—Petechiae—Methotrexate—colon cancer	0.00295	0.00347	CcSEcCtD
Hyoscyamine—Dysuria—Vincristine—colon cancer	0.00293	0.00345	CcSEcCtD
Hyoscyamine—Dysphagia—Fluorouracil—colon cancer	0.00292	0.00344	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Vincristine—colon cancer	0.00289	0.0034	CcSEcCtD
Hyoscyamine—Angina pectoris—Fluorouracil—colon cancer	0.00285	0.00335	CcSEcCtD
Hyoscyamine—Speech disorder—Methotrexate—colon cancer	0.00282	0.00332	CcSEcCtD
Hyoscyamine—Depression—Vincristine—colon cancer	0.00279	0.00328	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Vincristine—colon cancer	0.00276	0.00324	CcSEcCtD
Hyoscyamine—Myocardial infarction—Vincristine—colon cancer	0.00274	0.00323	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Irinotecan—colon cancer	0.00268	0.00316	CcSEcCtD
Hyoscyamine—Swelling—Capecitabine—colon cancer	0.00268	0.00316	CcSEcCtD
Hyoscyamine—Sweating—Vincristine—colon cancer	0.00268	0.00316	CcSEcCtD
Hyoscyamine—Myocardial infarction—Irinotecan—colon cancer	0.00267	0.00314	CcSEcCtD
Hyoscyamine—Eye pain—Capecitabine—colon cancer	0.00262	0.00308	CcSEcCtD
Hyoscyamine—Sweating—Irinotecan—colon cancer	0.00261	0.00307	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Fluorouracil—colon cancer	0.00257	0.00303	CcSEcCtD
Hyoscyamine—Dysarthria—Methotrexate—colon cancer	0.00256	0.00302	CcSEcCtD
Hyoscyamine—Myocardial infarction—Fluorouracil—colon cancer	0.00256	0.00301	CcSEcCtD
Hyoscyamine—Conjunctivitis—Fluorouracil—colon cancer	0.00253	0.00298	CcSEcCtD
Hyoscyamine—Amnesia—Capecitabine—colon cancer	0.00252	0.00296	CcSEcCtD
Hyoscyamine—Hallucination—Vincristine—colon cancer	0.0025	0.00294	CcSEcCtD
Hyoscyamine—Atrial fibrillation—Capecitabine—colon cancer	0.00249	0.00294	CcSEcCtD
Hyoscyamine—Bradycardia—Irinotecan—colon cancer	0.00249	0.00293	CcSEcCtD
Hyoscyamine—Thirst—Capecitabine—colon cancer	0.00248	0.00293	CcSEcCtD
Hyoscyamine—Respiratory failure—Methotrexate—colon cancer	0.00247	0.00291	CcSEcCtD
Hyoscyamine—Lethargy—Capecitabine—colon cancer	0.00241	0.00284	CcSEcCtD
Hyoscyamine—Hyponatraemia—Capecitabine—colon cancer	0.00237	0.0028	CcSEcCtD
Hyoscyamine—Osteoarthritis—Capecitabine—colon cancer	0.00236	0.00278	CcSEcCtD
Hyoscyamine—Depressed level of consciousness—Methotrexate—colon cancer	0.00234	0.00276	CcSEcCtD
Hyoscyamine—Skin exfoliation—Methotrexate—colon cancer	0.00231	0.00273	CcSEcCtD
Hyoscyamine—Flushing—Irinotecan—colon cancer	0.00227	0.00267	CcSEcCtD
Hyoscyamine—Irritability—Capecitabine—colon cancer	0.00226	0.00266	CcSEcCtD
Hyoscyamine—Urinary retention—Capecitabine—colon cancer	0.00225	0.00265	CcSEcCtD
Hyoscyamine—Cardiac arrest—Capecitabine—colon cancer	0.00225	0.00265	CcSEcCtD
Hyoscyamine—Ataxia—Capecitabine—colon cancer	0.00222	0.00262	CcSEcCtD
Hyoscyamine—Coma—Methotrexate—colon cancer	0.00222	0.00261	CcSEcCtD
Hyoscyamine—Dehydration—Capecitabine—colon cancer	0.0022	0.00259	CcSEcCtD
Hyoscyamine—Mental disorder—Vincristine—colon cancer	0.0022	0.00259	CcSEcCtD
Hyoscyamine—Arrhythmia—Irinotecan—colon cancer	0.00218	0.00257	CcSEcCtD
Hyoscyamine—Dry skin—Capecitabine—colon cancer	0.00217	0.00255	CcSEcCtD
Hyoscyamine—Pulmonary oedema—Methotrexate—colon cancer	0.00216	0.00254	CcSEcCtD
Hyoscyamine—Hypokalaemia—Capecitabine—colon cancer	0.00215	0.00253	CcSEcCtD
Hyoscyamine—Arrhythmia—Fluorouracil—colon cancer	0.00209	0.00246	CcSEcCtD
Hyoscyamine—Abdominal distension—Capecitabine—colon cancer	0.00206	0.00242	CcSEcCtD
Hyoscyamine—Dysphagia—Capecitabine—colon cancer	0.00204	0.00241	CcSEcCtD
Hyoscyamine—Erythema—Fluorouracil—colon cancer	0.00204	0.0024	CcSEcCtD
Hyoscyamine—Agitation—Vincristine—colon cancer	0.00201	0.00236	CcSEcCtD
Hyoscyamine—Angina pectoris—Capecitabine—colon cancer	0.00199	0.00234	CcSEcCtD
Hyoscyamine—Vertigo—Vincristine—colon cancer	0.00196	0.00231	CcSEcCtD
Hyoscyamine—Vision blurred—Fluorouracil—colon cancer	0.00192	0.00226	CcSEcCtD
Hyoscyamine—Vertigo—Irinotecan—colon cancer	0.00191	0.00225	CcSEcCtD
Hyoscyamine—Dysuria—Capecitabine—colon cancer	0.00191	0.00225	CcSEcCtD
Hyoscyamine—Syncope—Irinotecan—colon cancer	0.00191	0.00225	CcSEcCtD
Hyoscyamine—Convulsion—Vincristine—colon cancer	0.00189	0.00223	CcSEcCtD
Hyoscyamine—Loss of consciousness—Irinotecan—colon cancer	0.00187	0.0022	CcSEcCtD
Hyoscyamine—Hyperglycaemia—Capecitabine—colon cancer	0.00184	0.00217	CcSEcCtD
Hyoscyamine—Depression—Capecitabine—colon cancer	0.00182	0.00214	CcSEcCtD
Hyoscyamine—Acute coronary syndrome—Capecitabine—colon cancer	0.0018	0.00211	CcSEcCtD
Hyoscyamine—Lethargy—Methotrexate—colon cancer	0.0018	0.00211	CcSEcCtD
Hyoscyamine—Myocardial infarction—Capecitabine—colon cancer	0.00179	0.0021	CcSEcCtD
Hyoscyamine—Oedema—Vincristine—colon cancer	0.00178	0.0021	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Vincristine—colon cancer	0.00178	0.0021	CcSEcCtD
Hyoscyamine—Conjunctivitis—Capecitabine—colon cancer	0.00177	0.00209	CcSEcCtD
Hyoscyamine—Convulsion—Fluorouracil—colon cancer	0.00177	0.00208	CcSEcCtD
Hyoscyamine—Osteoarthritis—Methotrexate—colon cancer	0.00176	0.00207	CcSEcCtD
Hyoscyamine—Confusional state—Irinotecan—colon cancer	0.00175	0.00206	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Irinotecan—colon cancer	0.00174	0.00204	CcSEcCtD
Hyoscyamine—Oedema—Irinotecan—colon cancer	0.00174	0.00204	CcSEcCtD
Hyoscyamine—Chest pain—Fluorouracil—colon cancer	0.00173	0.00204	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Vincristine—colon cancer	0.00172	0.00203	CcSEcCtD
Hyoscyamine—Shock—Irinotecan—colon cancer	0.00171	0.00201	CcSEcCtD
Hyoscyamine—Irritability—Methotrexate—colon cancer	0.00168	0.00198	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Irinotecan—colon cancer	0.00168	0.00198	CcSEcCtD
Hyoscyamine—Confusional state—Fluorouracil—colon cancer	0.00168	0.00197	CcSEcCtD
Hyoscyamine—Hypotension—Vincristine—colon cancer	0.00167	0.00196	CcSEcCtD
Hyoscyamine—Bradycardia—Capecitabine—colon cancer	0.00167	0.00196	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Fluorouracil—colon cancer	0.00166	0.00196	CcSEcCtD
Hyoscyamine—Oedema—Fluorouracil—colon cancer	0.00166	0.00196	CcSEcCtD
Hyoscyamine—Ataxia—Methotrexate—colon cancer	0.00165	0.00195	CcSEcCtD
Hyoscyamine—Tachycardia—Fluorouracil—colon cancer	0.00162	0.00191	CcSEcCtD
Hyoscyamine—Hypotension—Irinotecan—colon cancer	0.00162	0.00191	CcSEcCtD
Hyoscyamine—Insomnia—Vincristine—colon cancer	0.00161	0.0019	CcSEcCtD
Hyoscyamine—Insomnia—Irinotecan—colon cancer	0.00157	0.00185	CcSEcCtD
Hyoscyamine—Hypotension—Fluorouracil—colon cancer	0.00155	0.00183	CcSEcCtD
Hyoscyamine—Dyspnoea—Irinotecan—colon cancer	0.00155	0.00182	CcSEcCtD
Hyoscyamine—Somnolence—Irinotecan—colon cancer	0.00154	0.00182	CcSEcCtD
Hyoscyamine—Fatigue—Vincristine—colon cancer	0.00154	0.00181	CcSEcCtD
Hyoscyamine—Dyspepsia—Irinotecan—colon cancer	0.00153	0.0018	CcSEcCtD
Hyoscyamine—Constipation—Vincristine—colon cancer	0.00152	0.0018	CcSEcCtD
Hyoscyamine—Pain—Vincristine—colon cancer	0.00152	0.0018	CcSEcCtD
Hyoscyamine—Flushing—Capecitabine—colon cancer	0.00152	0.00179	CcSEcCtD
Hyoscyamine—Insomnia—Fluorouracil—colon cancer	0.0015	0.00177	CcSEcCtD
Hyoscyamine—Fatigue—Irinotecan—colon cancer	0.0015	0.00176	CcSEcCtD
Hyoscyamine—Pain—Irinotecan—colon cancer	0.00148	0.00175	CcSEcCtD
Hyoscyamine—Constipation—Irinotecan—colon cancer	0.00148	0.00175	CcSEcCtD
Hyoscyamine—Dyspnoea—Fluorouracil—colon cancer	0.00148	0.00175	CcSEcCtD
Hyoscyamine—Somnolence—Fluorouracil—colon cancer	0.00148	0.00174	CcSEcCtD
Hyoscyamine—Dyspepsia—Fluorouracil—colon cancer	0.00146	0.00172	CcSEcCtD
Hyoscyamine—Arrhythmia—Capecitabine—colon cancer	0.00146	0.00172	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Vincristine—colon cancer	0.00146	0.00172	CcSEcCtD
Hyoscyamine—Mental disorder—Capecitabine—colon cancer	0.00143	0.00169	CcSEcCtD
Hyoscyamine—Feeling abnormal—Irinotecan—colon cancer	0.00143	0.00168	CcSEcCtD
Hyoscyamine—Erythema—Capecitabine—colon cancer	0.00142	0.00168	CcSEcCtD
Hyoscyamine—Dysuria—Methotrexate—colon cancer	0.00142	0.00167	CcSEcCtD
Hyoscyamine—Pain—Fluorouracil—colon cancer	0.00142	0.00167	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Irinotecan—colon cancer	0.00142	0.00167	CcSEcCtD
Hyoscyamine—Abdominal pain—Vincristine—colon cancer	0.00141	0.00166	CcSEcCtD
Hyoscyamine—Body temperature increased—Vincristine—colon cancer	0.00141	0.00166	CcSEcCtD
Hyoscyamine—Erectile dysfunction—Methotrexate—colon cancer	0.0014	0.00165	CcSEcCtD
Hyoscyamine—Dysgeusia—Capecitabine—colon cancer	0.00139	0.00164	CcSEcCtD
Hyoscyamine—Body temperature increased—Irinotecan—colon cancer	0.00137	0.00162	CcSEcCtD
Hyoscyamine—Abdominal pain—Irinotecan—colon cancer	0.00137	0.00162	CcSEcCtD
Hyoscyamine—Feeling abnormal—Fluorouracil—colon cancer	0.00137	0.00161	CcSEcCtD
Hyoscyamine—Drowsiness—Methotrexate—colon cancer	0.00136	0.0016	CcSEcCtD
Hyoscyamine—Depression—Methotrexate—colon cancer	0.00135	0.00159	CcSEcCtD
Hyoscyamine—Vision blurred—Capecitabine—colon cancer	0.00134	0.00158	CcSEcCtD
Hyoscyamine—Urticaria—Fluorouracil—colon cancer	0.00132	0.00156	CcSEcCtD
Hyoscyamine—Conjunctivitis—Methotrexate—colon cancer	0.00132	0.00155	CcSEcCtD
Hyoscyamine—Body temperature increased—Fluorouracil—colon cancer	0.00131	0.00155	CcSEcCtD
Hyoscyamine—Hypersensitivity—Vincristine—colon cancer	0.00131	0.00155	CcSEcCtD
Hyoscyamine—Sweating—Methotrexate—colon cancer	0.0013	0.00153	CcSEcCtD
Hyoscyamine—Vertigo—Capecitabine—colon cancer	0.00128	0.00151	CcSEcCtD
Hyoscyamine—Hypersensitivity—Irinotecan—colon cancer	0.00128	0.00151	CcSEcCtD
Hyoscyamine—Asthenia—Vincristine—colon cancer	0.00128	0.00151	CcSEcCtD
Hyoscyamine—Syncope—Capecitabine—colon cancer	0.00128	0.0015	CcSEcCtD
Hyoscyamine—Palpitations—Capecitabine—colon cancer	0.00126	0.00148	CcSEcCtD
Hyoscyamine—Loss of consciousness—Capecitabine—colon cancer	0.00125	0.00147	CcSEcCtD
Hyoscyamine—Asthenia—Irinotecan—colon cancer	0.00125	0.00147	CcSEcCtD
Hyoscyamine—Hypersensitivity—Fluorouracil—colon cancer	0.00123	0.00144	CcSEcCtD
Hyoscyamine—Diarrhoea—Vincristine—colon cancer	0.00122	0.00144	CcSEcCtD
Hyoscyamine—Chest pain—Capecitabine—colon cancer	0.00121	0.00143	CcSEcCtD
Hyoscyamine—Anxiety—Capecitabine—colon cancer	0.00121	0.00142	CcSEcCtD
Hyoscyamine—Diarrhoea—Irinotecan—colon cancer	0.00119	0.0014	CcSEcCtD
Hyoscyamine—Dry mouth—Capecitabine—colon cancer	0.00119	0.0014	CcSEcCtD
Hyoscyamine—Dizziness—Vincristine—colon cancer	0.00118	0.00139	CcSEcCtD
Hyoscyamine—Pruritus—Fluorouracil—colon cancer	0.00118	0.00139	CcSEcCtD
Hyoscyamine—Confusional state—Capecitabine—colon cancer	0.00117	0.00138	CcSEcCtD
Hyoscyamine—Oedema—Capecitabine—colon cancer	0.00116	0.00137	CcSEcCtD
Hyoscyamine—Dizziness—Irinotecan—colon cancer	0.00115	0.00135	CcSEcCtD
Hyoscyamine—Shock—Capecitabine—colon cancer	0.00114	0.00135	CcSEcCtD
Hyoscyamine—Diarrhoea—Fluorouracil—colon cancer	0.00114	0.00134	CcSEcCtD
Hyoscyamine—Tachycardia—Capecitabine—colon cancer	0.00113	0.00134	CcSEcCtD
Hyoscyamine—Vomiting—Vincristine—colon cancer	0.00113	0.00133	CcSEcCtD
Hyoscyamine—Rash—Vincristine—colon cancer	0.00112	0.00132	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Capecitabine—colon cancer	0.00112	0.00132	CcSEcCtD
Hyoscyamine—Dermatitis—Vincristine—colon cancer	0.00112	0.00132	CcSEcCtD
Hyoscyamine—Headache—Vincristine—colon cancer	0.00112	0.00132	CcSEcCtD
Hyoscyamine—Vomiting—Irinotecan—colon cancer	0.0011	0.0013	CcSEcCtD
Hyoscyamine—Dizziness—Fluorouracil—colon cancer	0.0011	0.00129	CcSEcCtD
Hyoscyamine—Rash—Irinotecan—colon cancer	0.00109	0.00129	CcSEcCtD
Hyoscyamine—Dermatitis—Irinotecan—colon cancer	0.00109	0.00129	CcSEcCtD
Hyoscyamine—Headache—Irinotecan—colon cancer	0.00109	0.00128	CcSEcCtD
Hyoscyamine—Hypotension—Capecitabine—colon cancer	0.00109	0.00128	CcSEcCtD
Hyoscyamine—Mental disorder—Methotrexate—colon cancer	0.00107	0.00126	CcSEcCtD
Hyoscyamine—Erythema—Methotrexate—colon cancer	0.00106	0.00125	CcSEcCtD
Hyoscyamine—Nausea—Vincristine—colon cancer	0.00106	0.00125	CcSEcCtD
Hyoscyamine—Vomiting—Fluorouracil—colon cancer	0.00106	0.00124	CcSEcCtD
Hyoscyamine—Insomnia—Capecitabine—colon cancer	0.00105	0.00124	CcSEcCtD
Hyoscyamine—Rash—Fluorouracil—colon cancer	0.00105	0.00123	CcSEcCtD
Hyoscyamine—Dermatitis—Fluorouracil—colon cancer	0.00105	0.00123	CcSEcCtD
Hyoscyamine—Headache—Fluorouracil—colon cancer	0.00104	0.00123	CcSEcCtD
Hyoscyamine—Dysgeusia—Methotrexate—colon cancer	0.00104	0.00122	CcSEcCtD
Hyoscyamine—Dyspnoea—Capecitabine—colon cancer	0.00104	0.00122	CcSEcCtD
Hyoscyamine—Nausea—Irinotecan—colon cancer	0.00103	0.00121	CcSEcCtD
Hyoscyamine—Dyspepsia—Capecitabine—colon cancer	0.00102	0.0012	CcSEcCtD
Hyoscyamine—Fatigue—Capecitabine—colon cancer	0.001	0.00118	CcSEcCtD
Hyoscyamine—Vision blurred—Methotrexate—colon cancer	0.000999	0.00118	CcSEcCtD
Hyoscyamine—Pain—Capecitabine—colon cancer	0.000994	0.00117	CcSEcCtD
Hyoscyamine—Constipation—Capecitabine—colon cancer	0.000994	0.00117	CcSEcCtD
Hyoscyamine—Nausea—Fluorouracil—colon cancer	0.000988	0.00116	CcSEcCtD
Hyoscyamine—Feeling abnormal—Capecitabine—colon cancer	0.000958	0.00113	CcSEcCtD
Hyoscyamine—Vertigo—Methotrexate—colon cancer	0.000952	0.00112	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Capecitabine—colon cancer	0.00095	0.00112	CcSEcCtD
Hyoscyamine—Urticaria—Capecitabine—colon cancer	0.000923	0.00109	CcSEcCtD
Hyoscyamine—Abdominal pain—Capecitabine—colon cancer	0.000919	0.00108	CcSEcCtD
Hyoscyamine—Body temperature increased—Capecitabine—colon cancer	0.000919	0.00108	CcSEcCtD
Hyoscyamine—Convulsion—Methotrexate—colon cancer	0.000918	0.00108	CcSEcCtD
Hyoscyamine—Chest pain—Methotrexate—colon cancer	0.000902	0.00106	CcSEcCtD
Hyoscyamine—Confusional state—Methotrexate—colon cancer	0.000872	0.00103	CcSEcCtD
Hyoscyamine—Anaphylactic shock—Methotrexate—colon cancer	0.000865	0.00102	CcSEcCtD
Hyoscyamine—Hypersensitivity—Capecitabine—colon cancer	0.000856	0.00101	CcSEcCtD
Hyoscyamine—Hyperhidrosis—Methotrexate—colon cancer	0.000836	0.000985	CcSEcCtD
Hyoscyamine—Asthenia—Capecitabine—colon cancer	0.000834	0.000982	CcSEcCtD
Hyoscyamine—Pruritus—Capecitabine—colon cancer	0.000822	0.000968	CcSEcCtD
Hyoscyamine—Hypotension—Methotrexate—colon cancer	0.000808	0.000952	CcSEcCtD
Hyoscyamine—Diarrhoea—Capecitabine—colon cancer	0.000795	0.000936	CcSEcCtD
Hyoscyamine—Insomnia—Methotrexate—colon cancer	0.000782	0.000921	CcSEcCtD
Hyoscyamine—Dyspnoea—Methotrexate—colon cancer	0.000771	0.000908	CcSEcCtD
Hyoscyamine—Somnolence—Methotrexate—colon cancer	0.000769	0.000906	CcSEcCtD
Hyoscyamine—Dizziness—Capecitabine—colon cancer	0.000768	0.000905	CcSEcCtD
Hyoscyamine—Dyspepsia—Methotrexate—colon cancer	0.000761	0.000897	CcSEcCtD
Hyoscyamine—Fatigue—Methotrexate—colon cancer	0.000746	0.000878	CcSEcCtD
Hyoscyamine—Pain—Methotrexate—colon cancer	0.00074	0.000871	CcSEcCtD
Hyoscyamine—Vomiting—Capecitabine—colon cancer	0.000739	0.00087	CcSEcCtD
Hyoscyamine—Rash—Capecitabine—colon cancer	0.000733	0.000863	CcSEcCtD
Hyoscyamine—Dermatitis—Capecitabine—colon cancer	0.000732	0.000862	CcSEcCtD
Hyoscyamine—Headache—Capecitabine—colon cancer	0.000728	0.000857	CcSEcCtD
Hyoscyamine—Feeling abnormal—Methotrexate—colon cancer	0.000713	0.000839	CcSEcCtD
Hyoscyamine—Gastrointestinal pain—Methotrexate—colon cancer	0.000707	0.000833	CcSEcCtD
Hyoscyamine—Nausea—Capecitabine—colon cancer	0.00069	0.000813	CcSEcCtD
Hyoscyamine—Urticaria—Methotrexate—colon cancer	0.000687	0.000809	CcSEcCtD
Hyoscyamine—Body temperature increased—Methotrexate—colon cancer	0.000684	0.000805	CcSEcCtD
Hyoscyamine—Abdominal pain—Methotrexate—colon cancer	0.000684	0.000805	CcSEcCtD
Hyoscyamine—Hypersensitivity—Methotrexate—colon cancer	0.000637	0.00075	CcSEcCtD
Hyoscyamine—Asthenia—Methotrexate—colon cancer	0.000621	0.000731	CcSEcCtD
Hyoscyamine—Pruritus—Methotrexate—colon cancer	0.000612	0.000721	CcSEcCtD
Hyoscyamine—Diarrhoea—Methotrexate—colon cancer	0.000592	0.000697	CcSEcCtD
Hyoscyamine—Dizziness—Methotrexate—colon cancer	0.000572	0.000674	CcSEcCtD
Hyoscyamine—Vomiting—Methotrexate—colon cancer	0.00055	0.000648	CcSEcCtD
Hyoscyamine—Rash—Methotrexate—colon cancer	0.000545	0.000642	CcSEcCtD
Hyoscyamine—Dermatitis—Methotrexate—colon cancer	0.000545	0.000642	CcSEcCtD
Hyoscyamine—Headache—Methotrexate—colon cancer	0.000542	0.000638	CcSEcCtD
Hyoscyamine—Nausea—Methotrexate—colon cancer	0.000514	0.000605	CcSEcCtD
